Impact of QT variables on clinical outcome of genotyped hypertrophic cardiomyopathy

Annals of Noninvasive Electrocardiology

Volumn 14, Issue 1, 2009, Pages 65-71

  Uchiyama, Katsuharu ^a   Hayashi, Kenshi ^a   Fujino, Noboru ^a   Konno, Tetsuo ^a   Sakamoto, Yuichiro ^a   Sakata, Kenji ^a   Kawashiri, Masa Aki ^a   Ino, Hidekazu ^a   Yamagishi, Masakazu ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Gene mutation; Hypertrophic cardiomyopathy; QT dispersion

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; ECG ABNORMALITY; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE TACHYCARDIA; HETEROZYGOTE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; SUDDEN DEATH;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CARDIOMYOPATHY, HYPERTROPHIC; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; YOUNG ADULT;

EID: 58449130146     PISSN: 1082720X     EISSN: 1542474X     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2008.00275.x     Document Type: Article

References (28)

1. Jarcho JA, McKenna W, Pare JA. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 1989 321 : 1372 1378.
2. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death. Revisited in a large non-referral-based patient population. Circulation 2000 102 : 858 864.
3. Maron BJ, Roberts WC, Edwards JE, et al. Sudden death in patients with hypertrophic cardiomyopathy: Characterization of 26 patients with functional limitation. Am J Cardiol 1978 41 : 803 810.
4. Buja G, Miorelli M, Turrini P, et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993 72 : 973 976.
5. Yetman AT, Hamilton RM, Benson LN, et al. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol 1998 32 : 1943 1950.
6. Shimizu M, Ino H, Okeie K, et al. T-peak to T-end interval may be a better predictor of high-risk patients with hypertrophic cardiomyopathy associated with a cardiac troponin I mutation than QT dispersion. Clin Cardiol 2002 25 : 335 339.
7. Kokado H, Shimizu M, Yoshio H, et al. Clinical features of hypertrophic cardiomyopathy caused by a Lys183 deletion mutation in the cardiac troponin I gene. Circulation 2000 102 : 663 669.
8. Fujino N, Shimizu M, Ino H, et al. A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. Am J Cardiol 2002 89 : 29 33.
9. Shimizu M, Ino H, Okeie K, et al. Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation. Am Heart J 2002 143 : 690 695.
10. Konno T, Shimizu M, Ino H, et al. A novel missense mutation in the myosin binding protein-C gene is responsible hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients. J Am Coll Cardiol 2003 41 : 781 786.
11. Konno T, Shimizu M, Ino H, et al. A novel mutation in the cardiac myosin-binding protein-C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death. Clin Sci (Lond) 2006 110 : 125 131.
12. Nishi H, Kimura A, Harada H, et al. Possible gene dose effect of a mutant cardiac beta-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 1994 200 : 549 556.
13. Fujino N, Shimizu M, Ino H, et al. Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy. Clin Cardiol 2001 24 : 397 402.
14. Fujino N, Shimizu M, Ino H, et al. A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. Am J Cardiol 2002 89 : 29 33.
15. Anan R, Shono H, Tei C. Novel cardiac beta-myosin heavy chain gene missense mutations (R869C and R870C) that cause familial hypertrophic cardiomyopathy. Hum Mutat 2000 15 : 584.
16. Dritsas A, Sbarouni E, Gilligan D, et al. QT-interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol 1992 15 : 739 742.
17. Shimizu W, Antzelevitch C. Sodium channel block with Mexiletine is effective in reducing dispersion of repolarization and preventing Torsade de Pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997 96 : 2038 2047.
18. Ryan MP, Cleland JF, French JA, et al. The standard electrocardiogram as a screening test for hypertrophic cardiomyopathy. Am J Cardiol 1995 76 : 689 694.
19. Romhilt DW, Estes EH. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968 75 : 752 758.
20. Charron P, Dubourg O, Desnos M, et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population. Circulation 1997 96 : 214 219.
21. Shimizu M, Ino H, Yamaguchi M, et al. Chronologic electrocardiographic changes in patients with hypertrophic cardiomyopathy associated with cardiac troponin I mutation. Am Heart J 2002 143 : 289 293.
22. Charron P, Dubourg O, Desnos M, et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 1998 97 : 2230 2236.
23. Zaidi M, Robert A, Fesler R, et al. Dispersion of ventricular repolarization in hypertrophic cardiomyopathy. J Electrocardiol 1996 29 (Suppl. 89 94.
24. Jouven X, Hagege A, Charron P, et al. Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy. Heart 2002 88 : 153 157.
25. Macfarlane PW, McLaughlin SC, Rodger JC. Influence of lead selection and population on automated measurement of QT dispersion. Circulation 1998 98 : 2160 2167.
26. Mayet J, Kanagaratnam P, Shahi M, et al. QT dispersion in athletic left ventricular hypertrophy. Am Heart J 1999 137 : 678 681.
27. Sakata K, Shimizu M, Ino H, et al. QT dispersion and left ventricular morphology in patients with hypertrophic cardiomyopathy. Heart 2003 89 : 882 886.
28. Elliott PM, Gimeno JR, Thaman R, et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart 2006 92 : 785 791.